My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

NovoCure Limited - Ordinary Shares (NQ:NVCR)

11.46 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Continued Uncertainty ↗

June 15, 2021

Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all.

Via Talk Markets

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗

June 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

Recap: NovoCure Q1 Earnings ↗

April 29, 2021

Shares of NovoCure (NASDAQ:NVCR) fell 2.7% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 200.00% year over...

Via Benzinga

Dreary Day ↗

June 14, 2021

Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold.

Via Talk Markets

Unheeding Markets ↗

June 10, 2021

Today oil prices rose over $70.

Via Talk Markets

Wednesday News And Catch-Up ↗

June 09, 2021

Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA.

Via Talk Markets

Topics Stocks

Juvenile Investing Mob ↗

June 08, 2021

Tech stocks did well in Europe but not in the US. The data are unconvincing.

Via Talk Markets

3 Unstoppable Stocks That Can Leave Dogecoin in the Dust ↗

June 05, 2021

These fundamentally strong stocks are much better bets than the over-hyped Dogecoin.

Via The Motley Fool

2 Innovative Growth Stocks to Buy for June ↗

May 28, 2021

Got cash? Consider these high-flying growth stocks.

Via The Motley Fool

Sterling At Five-Year High ↗

May 25, 2021

Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.

Via Talk Markets

Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma

May 25, 2021

From Novocure

Via Business Wire

Better Mood Day ↗

May 20, 2021

The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion.

Via Talk Markets

May Or May Not Happen ↗

May 18, 2021

Another day, another drop.

Via Talk Markets

Novocure Surges As FDA Allows A Six Months Shorter Lung Cancer Study ↗

May 18, 2021

Novocure said Tuesday it could have the results of a pivotal lung cancer study six months sooner than expected, leading NVCR stock to pop.

Via Investor's Business Daily

Novocure Gets FDA Approval For Reducing Sample Size For Late-Stage Pivotal LUNAR Lung Cancer Study ↗

May 18, 2021

The FDA has approved Novocure Ltd's (NASDAQ: NVCR) Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for its LUNAR Phase 3...

Via Benzinga

Novocure Announces FDA Approval of IDE Supplement for Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer

May 18, 2021

From Novocure

Via Business Wire

Friday Of The Heavy Week ↗

May 14, 2021

There is nothing like a pending weekend to push Wall Street into recuperation and this worked today

Via Talk Markets

Could Novocure Be a Millionaire-Maker Stock? ↗

May 12, 2021

It's a good stock, but it might struggle to make you rich overnight.

Via The Motley Fool

Heavy Global Erosion ↗

May 11, 2021

It is an everything-down day. Even the news is down because commenters are being careful.

Via Talk Markets

Gold Up Four Days In A Row ↗

May 10, 2021

The dollar is at a nearly 3 month low.

Via Talk Markets

Calm Markets Day ↗

May 07, 2021

Despite seriously disappointing April jobless numbers, markets are gaining all the same.

Via Talk Markets

Finns and Danes ↗

May 05, 2021

Stock markets are still uncertain whether to rise or fall after the Tuesday debacle.

Via Talk Markets

Cramer Weighs In On Penn National Gaming, Palantir And More ↗

May 04, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he happens to like Penn National Gaming, Inc (NASDAQ: PENN) very much and it deserves to trade higher. Alcoa (...

Via Benzinga

Unusually Heavy Friday ↗

April 30, 2021

Today is a heavy news day, which is unusual for a Friday. We start with the largest company's lamentable report, follow with another confusing result, then a hopeful drug company report, and finish...

Via Talk Markets

Is Novocure Stock Overvalued? ↗

April 30, 2021

Did the market overreact to the company's good news?

Via The Motley Fool

Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon ↗

April 30, 2021

The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded.

Via Investor's Business Daily

Another Heavy News Day ↗

April 29, 2021

For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week.

Via Talk Markets

NovoCure (NVCR) Q1 2021 Earnings Call Transcript ↗

April 29, 2021

NVCR earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

Novocure Reports Surprise Loss As Revenue Falls Short ↗

April 29, 2021

Novocure reported a surprise loss as the cancer-fighting medtech missed on revenue. NVCR stock fell.

Via Investor's Business Daily

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.